Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16673360 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL9785166 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL9785134 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL999183 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL1785452 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL16673485 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL9436082 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL811812 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL2166417 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL16673619 | 1.00 | TSHR (0.50) | TSHRTHRBPTPN7HMGCRDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102417839-B | Fuel antistatic agent and application thereof | OIL RES INST OF THE AIR FORCE PLA | 2013-03-27 | — | — | CN | claimed |
| CN-102417839-A | Fuel antistatic agent and application thereof | OIL RES INST OF THE AIR FORCE PLA | 2012-04-18 | — | — | CN | claimed |
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2024-02-29 | — | — | US | disclosed |
| EP-3851447-B1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2023-09-06 | — | — | EP | disclosed |
| CN-112512470-B | Liquid polymer solution for treating nonwoven webs | 聚合物绿色有限责任公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-115135141-A | Multi-layer absorbent product and process for making absorbent layer | 宝利格林有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-113302267-B | Sulfur-based extreme pressure agent and metalworking oil | DIC株式会社 | 2022-09-06 | — | — | CN | disclosed |
| US-20210386693-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2021-12-16 | — | — | US | disclosed |
| CN-113302267-A | Sulfur-based extreme pressure agent and metalworking oil | DIC株式会社 | 2021-08-24 | — | — | CN | disclosed |
| EP-2862581-B1 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | BHI LP (CA) | 2021-08-11 | — | — | EP | disclosed |
| EP-3851447-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BHI Limited Partnership (CA) | 2021-07-21 | — | — | EP | disclosed |
| US-7388102-B2 | Organosilicone derivatives of amino hydroxybenzophenones and their use as UV-A filters in cosmetic preparations | DSM IP ASSETS B.V. (NL) | 2008-06-17 | — | — | US | disclosed |
| CN-101083975-A | Hair treatment agent and hair waving method | SHOWA DENKO KK (JP) | 2007-12-05 | — | — | CN | disclosed |
| US-20050255066-A1 | Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations | DSM NUTRITIONAL PRODUCTS LTD F/K/A ROCHE VITAMINS AG (CH) | 2005-11-17 | — | — | US | disclosed |
| EP-1104401-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | Akzo Nobel N.V. (NL) | 2001-06-06 | — | — | EP | disclosed |
| WO-2000009478-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | AKZO NOBEL N.V. (NL) | 2000-02-24 | — | — | WO | disclosed |
| US-4800526-A | Memory element for information storage and retrieval system and associated process | GAF CORPORATION (US) | 1989-01-24 | — | — | US | disclosed |
| US-4535108-A | PHENOL ESTER SULFONIC ACID METAL SALT ADDITIVE | GENERAL ELECTRIC COMPANY (US) | 1985-08-13 | — | — | US | disclosed |
| WO-1982002896-A1 | COMPOSITION,COMPOUND AND PROCESS | GEN ELECTRIC (US) | 1982-09-02 | — | — | WO | disclosed |
| US-4142014-A | THERMALLY RESISTANT RELEASE AGENTS | GAF CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | APP, PSEN1, PSEN2 | TSHR 4797/4885THRB 4622/4885PTPN7 3363/4885 |
| US-20050255066-A1 | Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations | CUTA, TYR, ERCC5 | TSHR 4676/4885THRB 3653/4885PTPN7 2023/4885 |
| US-20210386693-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | APP, PSEN1, PSEN2 | TSHR 4797/4885THRB 4606/4885PTPN7 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.